Sep 29 - By Associated Press
Connecticut officials say Eli Lilly & Co. has agreed to a $25 million settlement with the state over claims the drugmaker marketed its anti-psychotic drug Zyprexa for unapproved uses and harmed patients.

Jan 15 - By Tom Murphy, AP Business Writer
Eli Lilly & Co. taught its sales force a catchy slogan to peddle the antipsychotic drug Zyprexa for treating the elderly.
Jan 14 - By Associated Press
Drugmaker Eli Lilly and Co. is close to agreeing to a $1.4 billion settlement related to a government investigation into the marketing of its top seller Zyprexa, according to a New York Times report.
Oct 21 - By Tom Murphy, AP Business Writer
Eli Lilly and Co. will take a big bite out of its third-quarter earnings with a $1.4 billion charge related to a government investigation over marketing practices for the anti-psychotic Zyprexa.
Jul 3 - By Charles Wilson, Associated Press Writer
A federal judge in New York is urging Eli Lilly and Co. to settle a multibillion-dollar lawsuit filed by insurance companies, unions and others who claim the pharmaceutical giant overpriced its top-selling drug Zyprexa and exaggerated its usefulness.

Mar 26 - By Associated Press
Eli Lilly and Co. and Alaska announced a $15 million settlement Wednesday in the state's lawsuit over the use of the drug Zyprexa in its Medicaid program.
Mar 5 - By Dan Joling, Associated Press Writer
Eli Lilly and Co. failed to adequately warn doctors and patients of dangerous side effects associated with its drug Zyprexa, an attorney for Alaska said Wednesday in opening arguments in the state's lawsuit against the drug maker.
Jan 31 - By Tom Murphy, AP Business Writer
Eli Lilly and Co. has paid more than $1 billion to settle legal battles over its top-selling drug Zyprexa, and it might have to write another large check soon. But a new lawsuit says the company should have known better.
Jan 30 - By Associated Press
Eli Lilly and Co. and federal prosecutors are exploring a settlement of an investigation into the drugmaker's marketing of its top seller, the anti-psychotic Zyprexa, The New York Times reported Wednesday.